🇺🇸 Typhoid Vaccine in United States
53 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 53
Most-reported reactions
- Malaise — 8 reports (15.09%)
- Dizziness — 6 reports (11.32%)
- Drug Exposure During Pregnancy — 6 reports (11.32%)
- Nausea — 6 reports (11.32%)
- Off Label Use — 6 reports (11.32%)
- Pyrexia — 5 reports (9.43%)
- Alopecia — 4 reports (7.55%)
- Anxiety — 4 reports (7.55%)
- Drug Hypersensitivity — 4 reports (7.55%)
- Fatigue — 4 reports (7.55%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Typhoid Vaccine approved in United States?
Typhoid Vaccine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Typhoid Vaccine in United States?
University of Oxford is the originator. The local marketing authorisation holder may differ — check the official source linked above.